Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

詳細記述

保存先:
書誌詳細
主要な著者: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2022-04-01
シリーズ:CJC Open
オンライン･アクセス:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料